This patent covers the composition of matter for the myofibrillogenesis-inducing RNA (MIR) molecule. MIR appears to be important for myofibrillogenesis (a stage in cardiogenesis) in a type of salamander called the Mexican axolotl. Since the claims cover composition of matter for a molecule found on a non-human species, it will be interesting to see how commercialization of this patent will be performed.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.